menu ☰
menu ˟

Iluvien finds niche for treating DME

09 Oct 2015
Backed by solid clinical trial data, Iluvien has become an invaluable third-level treatment option for chronic diabetic macular edema, according to one clinician.Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg, Alimera Sciences) is a non...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.